• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Best Practices Plans Can Take in the Medicaid Redetermination Process to Prevent Members Losing Coverage


Briana Contreras of MHE spoke with Leah Dewey of Cotiviti in this month’s podcast episode about what she’s seeing as the process of Medicaid Redetermination is well underway.

To listen to more episodes featured on Tuning Into The C-Suite, visit us on Spotify, Apple Podcasts and iHeartRadio.



Briana Contreras, an editor of Managed Healthcare Executive, spoke with Leah Dewey, vice president of clinical and consumer engagement operations at Cotiviti, in this month’s podcast episode. In our discussion, Leah talked about what she’s seeing as the process of Medicaid Redetermination is well underway and some of the issues affecting consumers, as many are at risk of losing coverage. Leah also shared best practices for health plans when reaching out to consumers and ways to keep members informed and engaged in the redetermination process.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.